(NASDAQ: OPK) Opko Health's forecast annual revenue growth rate of 2.24% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Opko Health's revenue in 2024 is $863,495,000.On average, 5 Wall Street analysts forecast OPK's revenue for 2024 to be $533,857,979,372, with the lowest OPK revenue forecast at $493,470,100,236, and the highest OPK revenue forecast at $550,658,266,513. On average, 5 Wall Street analysts forecast OPK's revenue for 2025 to be $587,562,581,298, with the lowest OPK revenue forecast at $552,017,400,264, and the highest OPK revenue forecast at $638,611,644,972.
In 2026, OPK is forecast to generate $643,727,563,808 in revenue, with the lowest revenue forecast at $641,511,130,307 and the highest revenue forecast at $647,574,957,810.